CAC
IMGN

Cowen and Company’s Immunogen Inc IMGN Stock Holding History

Cowen and Company’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-131,099
Closed -$3.89M – 789
2023
Q4 		$3.89M Buy
+131,099
New +$2.61M 0.26% 67

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cowen and Company's IMGN Position: Q1 2024 in Review

Cowen and Company sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 131,099 shares — an estimated $3.89M sold.

Cowen and Company first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $3.89M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Cowen and Company reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Cowen and Company sold 131,099 Immunogen Inc shares in Q1 2024, an estimated $3.89M.
  • Cowen and Company first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Cowen and Company's Immunogen Inc position peaked at $3.89M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.